law.justia.com/cases/massachusetts/supreme-court/2018/sjc-12347.html

A plaintiff who alleges that he was injured from his use of a generic drug because of a failure to warn of the drug's side effects cannot bring a common-law ...

caselaw.findlaw.com/nj-superior-court-appellate-division/1348227.html

Case opinion for NJ Superior Court, Appellate Division McDARBY v. MERCK CO INC. Read the Court's full decision on FindLaw.

www.cafc.uscourts.gov/sites/default/files/opinions-orders/16-2302.Opinion.4-24-2018.1.PDF

Apr 25, 2018 ... GILEAD SCIENCES, INC. v. MERCK & CO., INC. 3. 1–3, 5, 7, and 9-11 of the '712 patent) as well as Gilead's closely related defense that Merck ...

www.imedpub.com/articles/development-and-validation-of-an-hplcdadmethod-for-the-determination-of-coumarinin-syrups-with-guaco-and-critical-analysis-ofdrug.php?aid=20707

Instrumentation: We use an analytical balance (Ohaus Co, USA 0.00001 g/ 0.0001) ... (HPLC-DAD) and the program used for data analysis was the Merck- Hitachi ... deviation (SD) the coefficient of variation (CV%) and simple uncertainty (Inc.). ... was done in the isocratic mode, using acetonitrile: water (40:60; v/v) at a flow ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5130276

Nov 30, 2016 ... ... D. Paré,8,9 Yohan Bossé,3,10 Tommaso A. Dragani,2,* and Francesca ...... One of the authors (D.N.) has an affiliation to a commercial funder of this research (Merck & Co. Inc.); the funder provided support in the form of salary for the author .... Renzoni E, Srihari V, Sestini P. Pathogenesis of idiopathic ...

cancerres.aacrjournals.org/content/canres/52/12/3347.full.pdf

Department of Safety Assessment, Merck Sharp and Dohme Research Laboratories, West Point, ... demonstration of Vru.v mutations in mouse liver tumors, establishing a ... chased from CCR, Inc., Chanhassen, MN. .... DMBA- induced tumors contained predominantly Ki-ras co ..... Dragani, T. A., Manenti, G., Colombo. B. M. ...

www.cell.com/fulltext/S0092-8674(00)81132-0

It is worth noting that these invasive tumor cells incorporated BrdU ..... ∣∣ Present address: Human Genetics, Merck Research Laboratories, West Point, ... between the University of Tokyo and Banyu Pharmaceutical Co.; grants from ... Gariboldi M; De Gregorio L; Ferrari S; Manenti G; Pierotti M.A; Bianchi M.E; Dragani T.A.

www.jbc.org/content/287/20/16849.full.pdf

Sep 30, 2011 ... the pSG5 vector from Dr. B. P. Kennedy, Merck Frosst Centre ... Seno (Shionogi Research Laboratories, Shionogi & Co. Ltd.,. Osaka, Japan) (38). ...... Mariggio`, S., Filippi, B. M., Iurisci, C., Dragani, L. K., De Falco, V., Santoro,.

www.jbc.org/content/287/20/16849.full

May 11, 2012 ... ... anti-p38 antibody were from Cell Signaling Technology, Inc. (Beverly, MA). .... In contrast, 50 μm sPLA2IIA inhibitor-I, which inhibits class II and V .... With these IMLF−/− cells co-transfected with FcγR and GFP-PLA2IVα, we also took ..... L. Dragani (Consorzio Mario Negri Sud) for the mass spectrometry ...